Give it a rest from reading these kinds of legal pleadings :- ) The outcome of the Copaxone patent case is important to MNTA, but it is not nearly as important as whether the FDA approves MNTA’s Copaxone ANDA and whether the FDA approves MYL’s Copaxone ANDA.